SynthesisThe Cochrane database of systematic reviews2022

Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.

Josefine Clement Freiberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.